Cholestech
This article was originally published in The Gray Sheet
Executive Summary
Liver function alanine aminotransferase (ALT) test will launch June 1 under a Clinical Laboratory Improvement Amendments (CLIA) waiver, firm announces April 17. Classification establishes Cholestech's ALT product as a unique test for liver-related diseases. Five-minute enzyme test will operate on the Cholestech's L-D-X system